Core Insights - The company has entered the core supply chain of invasive brain-computer interface (BCI) products and is collaborating with downstream BCI clients to facilitate efficient commercialization from laboratory research to mass production, currently generating small-scale sales revenue [1][2] - The company is a strategic partner and core supplier for global cochlear implant leaders, focusing on the development and production of cochlear implant components [1] Invasive BCI Product Development - The company is enhancing the long-term stability and biocompatibility of implanted components in the invasive BCI sector, optimizing material safety and rejection response testing [2] - The company aims to provide reliable product solutions that are suitable for long-term implantation, low rejection rates, and mass production capabilities [2] Semi-invasive and Non-invasive BCI Solutions - In the semi-invasive BCI area, the company offers long-term implant product solutions along with related surgical assistance instruments and consumables [2] - For non-invasive BCI products, the company focuses on developing small, portable, and stable quality components and consumables [2] Market Trends and Collaboration - The maturity of BCI products and their application scenarios are improving as downstream clients enhance their product performance [2] - The company is actively working with downstream BCI clients to support the transition from laboratory development to mass production, although the revenue from this business is currently limited [2]
美好医疗：与脑机接口客户深入合作 已产生小规模销售收入